Comparison of Image Based Robotic Total Knee Arthroplasty Vs Imageless Augmented Reality Assisted Total Knee Arthroplasty

Launched by MEDISCH CENTRUM LATEM · Mar 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to perform total knee replacement surgery for patients with advanced knee osteoarthritis, which is when the cartilage in the knee wears down, causing pain and difficulty moving. One method uses a robot to help place the knee replacement parts accurately, while the other uses augmented reality technology to guide the surgeon. Both techniques are commonly used, and the goal of the study is to see if they are equally effective in ensuring the knee replacement is placed correctly, which can improve the overall outcome for patients.

To participate in this study, individuals aged 18 to 85 who are scheduled for their first total knee replacement surgery due to osteoarthritis may be eligible. However, those who have had knee surgery recently, have certain medical conditions, or are involved in other clinical trials cannot participate. Participants will be asked to sign a consent form and can expect to receive personalized care during the trial, helping researchers learn more about which surgical technique might be best for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects from 18 years up to 85 years old
• • Patients eligible and planned for a primary Total Knee Arthroplasty
• • Patients willing to sign the informed consent form (ICF) for participating in this study
• • Indication of surgery is primary osteoarthritis
• Exclusion Criteria:
• • Revision knee surgery
• • Other medical conditions contributing to the rehabilitation process of the TKA according to the surgeon, such as Parkinson's Disease, dementia, multiple sclerosis and cerebral vascular accident
• • The patient received a TKA within the last three months or has a TKA planned in the next three months, for the contralateral knee
• • Patient is participating in another clinical trial
• • Patient is not able to understand Dutch, French or English
• • Patients who did not meet all of the inclusion criteria